
NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

